nodes	percent_of_prediction	percent_of_DWPC	metapath
Estramustine—Estropipate—osteoporosis	0.119	0.328	CrCtD
Estramustine—ESR2—osteoporosis	0.0989	0.619	CbGaD
Estramustine—Conjugated Estrogens—osteoporosis	0.0905	0.249	CrCtD
Estramustine—Estradiol—osteoporosis	0.0779	0.214	CrCtD
Estramustine—Ethinyl Estradiol—osteoporosis	0.076	0.209	CrCtD
Estramustine—ESR1—osteoporosis	0.0609	0.381	CbGaD
Estramustine—ESR2—Estropipate—osteoporosis	0.0388	0.19	CbGbCtD
Estramustine—ESR2—Raloxifene—osteoporosis	0.0259	0.127	CbGbCtD
Estramustine—ESR2—Ethinyl Estradiol—osteoporosis	0.025	0.122	CbGbCtD
Estramustine—ESR1—Estropipate—osteoporosis	0.0199	0.0973	CbGbCtD
Estramustine—ESR2—Conjugated Estrogens—osteoporosis	0.0184	0.0899	CbGbCtD
Estramustine—ESR2—Estradiol—osteoporosis	0.0161	0.0789	CbGbCtD
Estramustine—Estriol—Estropipate—osteoporosis	0.0147	0.0638	CrCrCtD
Estramustine—ESR1—Raloxifene—osteoporosis	0.0133	0.0649	CbGbCtD
Estramustine—ESR1—Ethinyl Estradiol—osteoporosis	0.0128	0.0627	CbGbCtD
Estramustine—Conjugated Estrogens—Estropipate—osteoporosis	0.0125	0.0543	CrCrCtD
Estramustine—Estriol—Conjugated Estrogens—osteoporosis	0.0111	0.0483	CrCrCtD
Estramustine—Estriol—Estradiol—osteoporosis	0.00957	0.0416	CrCrCtD
Estramustine—Estropipate—Conjugated Estrogens—osteoporosis	0.00947	0.0412	CrCrCtD
Estramustine—ESR1—Conjugated Estrogens—osteoporosis	0.0094	0.046	CbGbCtD
Estramustine—Estriol—Ethinyl Estradiol—osteoporosis	0.00934	0.0406	CrCrCtD
Estramustine—Estrone—Estropipate—osteoporosis	0.00926	0.0403	CrCrCtD
Estramustine—Estradiol—Estropipate—osteoporosis	0.00926	0.0403	CrCrCtD
Estramustine—Mestranol—Estropipate—osteoporosis	0.00926	0.0403	CrCrCtD
Estramustine—Quinestrol—Estropipate—osteoporosis	0.00926	0.0403	CrCrCtD
Estramustine—Ethinyl Estradiol—Estropipate—osteoporosis	0.00882	0.0384	CrCrCtD
Estramustine—ESR1—Estradiol—osteoporosis	0.00825	0.0404	CbGbCtD
Estramustine—Estropipate—Estradiol—osteoporosis	0.00815	0.0354	CrCrCtD
Estramustine—Conjugated Estrogens—Estradiol—osteoporosis	0.00815	0.0354	CrCrCtD
Estramustine—Conjugated Estrogens—Ethinyl Estradiol—osteoporosis	0.00795	0.0346	CrCrCtD
Estramustine—Estropipate—Ethinyl Estradiol—osteoporosis	0.00795	0.0346	CrCrCtD
Estramustine—Quinestrol—Conjugated Estrogens—osteoporosis	0.00701	0.0305	CrCrCtD
Estramustine—Estradiol—Conjugated Estrogens—osteoporosis	0.00701	0.0305	CrCrCtD
Estramustine—Mestranol—Conjugated Estrogens—osteoporosis	0.00701	0.0305	CrCrCtD
Estramustine—Estrone—Conjugated Estrogens—osteoporosis	0.00701	0.0305	CrCrCtD
Estramustine—Ethinyl Estradiol—Conjugated Estrogens—osteoporosis	0.00668	0.0291	CrCrCtD
Estramustine—Quinestrol—Estradiol—osteoporosis	0.00604	0.0263	CrCrCtD
Estramustine—Mestranol—Estradiol—osteoporosis	0.00604	0.0263	CrCrCtD
Estramustine—Estrone—Estradiol—osteoporosis	0.00604	0.0263	CrCrCtD
Estramustine—Estrone—Ethinyl Estradiol—osteoporosis	0.00589	0.0256	CrCrCtD
Estramustine—Quinestrol—Ethinyl Estradiol—osteoporosis	0.00589	0.0256	CrCrCtD
Estramustine—Estradiol—Ethinyl Estradiol—osteoporosis	0.00589	0.0256	CrCrCtD
Estramustine—Mestranol—Ethinyl Estradiol—osteoporosis	0.00589	0.0256	CrCrCtD
Estramustine—Ethinyl Estradiol—Estradiol—osteoporosis	0.00575	0.025	CrCrCtD
Estramustine—Testosterone—Estradiol—osteoporosis	0.00309	0.0134	CrCrCtD
Estramustine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0022	0.0107	CbGbCtD
Estramustine—CYP3A4—Estropipate—osteoporosis	0.00204	0.00999	CbGbCtD
Estramustine—CYP3A4—Calcitriol—osteoporosis	0.00204	0.00999	CbGbCtD
Estramustine—CYP3A4—Ergocalciferol—osteoporosis	0.00163	0.00799	CbGbCtD
Estramustine—ABCB1—Conjugated Estrogens—osteoporosis	0.00161	0.00789	CbGbCtD
Estramustine—ABCB1—Estradiol—osteoporosis	0.00141	0.00693	CbGbCtD
Estramustine—CYP3A4—Raloxifene—osteoporosis	0.00136	0.00667	CbGbCtD
Estramustine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00132	0.00644	CbGbCtD
Estramustine—CYP3A4—Cholecalciferol—osteoporosis	0.00105	0.00515	CbGbCtD
Estramustine—CYP3A4—Conjugated Estrogens—osteoporosis	0.000965	0.00473	CbGbCtD
Estramustine—CYP3A4—Estradiol—osteoporosis	0.000848	0.00415	CbGbCtD
Estramustine—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.000249	0.0749	CbGpPWpGaD
Estramustine—Conjugated Estrogens—SLC51A—osteoporosis	0.000227	0.136	CrCbGaD
Estramustine—Cerebrovascular accident—Estropipate—osteoporosis	0.00017	0.00455	CcSEcCtD
Estramustine—Libido decreased—Calcitriol—osteoporosis	0.000168	0.00451	CcSEcCtD
Estramustine—Thirst—Ibandronate—osteoporosis	0.000168	0.00449	CcSEcCtD
Estramustine—Cramps of lower extremities—Risedronate—osteoporosis	0.000166	0.00445	CcSEcCtD
Estramustine—Cerebrovascular accident—Raloxifene—osteoporosis	0.000164	0.0044	CcSEcCtD
Estramustine—Thirst—Calcitriol—osteoporosis	0.000164	0.00439	CcSEcCtD
Estramustine—Pancytopenia—Etidronic acid—osteoporosis	0.000158	0.00423	CcSEcCtD
Estramustine—Mood swings—Estropipate—osteoporosis	0.000158	0.00422	CcSEcCtD
Estramustine—Disturbance in sexual arousal—Calcitriol—osteoporosis	0.000155	0.00415	CcSEcCtD
Estramustine—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.000154	0.0462	CbGpPWpGaD
Estramustine—Dry skin—Alendronate—osteoporosis	0.00015	0.00402	CcSEcCtD
Estramustine—Libido decreased—Ethinyl Estradiol—osteoporosis	0.000145	0.00389	CcSEcCtD
Estramustine—Thrombophlebitis—Pamidronate—osteoporosis	0.000144	0.00387	CcSEcCtD
Estramustine—Hot flush—Ethinyl Estradiol—osteoporosis	0.000144	0.00386	CcSEcCtD
Estramustine—Oedema—Calcium Acetate—osteoporosis	0.000144	0.00385	CcSEcCtD
Estramustine—Menopausal symptoms—Ethinyl Estradiol—osteoporosis	0.000143	0.00383	CcSEcCtD
Estramustine—MAP2—LKB1 signaling events—ESR1—osteoporosis	0.000141	0.0423	CbGpPWpGaD
Estramustine—Cramps of lower extremities—Conjugated Estrogens—osteoporosis	0.000139	0.00372	CcSEcCtD
Estramustine—Tenderness—Estradiol—osteoporosis	0.000139	0.00372	CcSEcCtD
Estramustine—Abdominal discomfort—Estropipate—osteoporosis	0.000138	0.00369	CcSEcCtD
Estramustine—Cardiac failure congestive—Pamidronate—osteoporosis	0.000138	0.00369	CcSEcCtD
Estramustine—Cerebrovascular accident—Ethinyl Estradiol—osteoporosis	0.000138	0.00368	CcSEcCtD
Estramustine—Anorexia—Calcium Acetate—osteoporosis	0.000137	0.00367	CcSEcCtD
Estramustine—Abdominal discomfort—Alendronate—osteoporosis	0.000136	0.00363	CcSEcCtD
Estramustine—Disturbance in sexual arousal—Ethinyl Estradiol—osteoporosis	0.000134	0.00358	CcSEcCtD
Estramustine—Estriol—ESR2—osteoporosis	0.000134	0.0799	CrCbGaD
Estramustine—Affect lability—Ethinyl Estradiol—osteoporosis	0.000133	0.00355	CcSEcCtD
Estramustine—Abdominal discomfort—Ibandronate—osteoporosis	0.000132	0.00354	CcSEcCtD
Estramustine—Depression—Estropipate—osteoporosis	0.000128	0.00342	CcSEcCtD
Estramustine—Mood swings—Ethinyl Estradiol—osteoporosis	0.000128	0.00342	CcSEcCtD
Estramustine—Lethargy—Pamidronate—osteoporosis	0.000128	0.00341	CcSEcCtD
Estramustine—Thrombophlebitis—Conjugated Estrogens—osteoporosis	0.000127	0.0034	CcSEcCtD
Estramustine—Eye pain—Zoledronate—osteoporosis	0.000126	0.00339	CcSEcCtD
Estramustine—Acute coronary syndrome—Estropipate—osteoporosis	0.000126	0.00338	CcSEcCtD
Estramustine—Myocardial infarction—Estropipate—osteoporosis	0.000126	0.00336	CcSEcCtD
Estramustine—Decreased appetite—Calcium Acetate—osteoporosis	0.000125	0.00335	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Pamidronate—osteoporosis	0.000125	0.00335	CcSEcCtD
Estramustine—Quinestrol—ESR1—osteoporosis	0.000124	0.0744	CrCbGaD
Estramustine—Depression—Raloxifene—osteoporosis	0.000124	0.00332	CcSEcCtD
Estramustine—Depression—Ibandronate—osteoporosis	0.000123	0.00328	CcSEcCtD
Estramustine—Estriol—SHBG—osteoporosis	0.000122	0.0728	CrCbGaD
Estramustine—Liver function test abnormal—Risedronate—osteoporosis	0.000121	0.00325	CcSEcCtD
Estramustine—Anorexia—Ergocalciferol—osteoporosis	0.000121	0.00325	CcSEcCtD
Estramustine—Cardiac failure congestive—Conjugated Estrogens—osteoporosis	0.000121	0.00325	CcSEcCtD
Estramustine—ESR1—Signaling events mediated by HDAC Class II—TUBA1B—osteoporosis	0.000121	0.0363	CbGpPWpGaD
Estramustine—Thirst—Zoledronate—osteoporosis	0.00012	0.00321	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.00012	0.0359	CbGpPWpGaD
Estramustine—Alopecia—Etidronic acid—osteoporosis	0.000118	0.00315	CcSEcCtD
Estramustine—Lethargy—Zoledronate—osteoporosis	0.000116	0.00312	CcSEcCtD
Estramustine—Skin exfoliation—Estradiol—osteoporosis	0.000116	0.0031	CcSEcCtD
Estramustine—Liver function test abnormal—Pamidronate—osteoporosis	0.000115	0.00309	CcSEcCtD
Estramustine—Flatulence—Etidronic acid—osteoporosis	0.000114	0.00306	CcSEcCtD
Estramustine—Cerebrovascular accident—Conjugated Estrogens—osteoporosis	0.000112	0.003	CcSEcCtD
Estramustine—Muscle spasms—Etidronic acid—osteoporosis	0.000111	0.00298	CcSEcCtD
Estramustine—Cramps of lower extremities—Estradiol—osteoporosis	0.000111	0.00298	CcSEcCtD
Estramustine—Decreased appetite—Ergocalciferol—osteoporosis	0.000111	0.00296	CcSEcCtD
Estramustine—Abdominal discomfort—Risedronate—osteoporosis	0.000109	0.00292	CcSEcCtD
Estramustine—Gynaecomastia—Estradiol—osteoporosis	0.000108	0.0029	CcSEcCtD
Estramustine—Mood swings—Conjugated Estrogens—osteoporosis	0.000104	0.00279	CcSEcCtD
Estramustine—Leukopenia—Etidronic acid—osteoporosis	0.000104	0.00278	CcSEcCtD
Estramustine—Depression—Ethinyl Estradiol—osteoporosis	0.000104	0.00277	CcSEcCtD
Estramustine—Flushing—Raloxifene—osteoporosis	0.000103	0.00277	CcSEcCtD
Estramustine—ESR2—Ovarian Infertility Genes—CYP19A1—osteoporosis	0.000103	0.0309	CbGpPWpGaD
Estramustine—Acute coronary syndrome—Ethinyl Estradiol—osteoporosis	0.000102	0.00274	CcSEcCtD
Estramustine—Estropipate—ESR2—osteoporosis	0.000102	0.0611	CrCbGaD
Estramustine—Myocardial infarction—Ethinyl Estradiol—osteoporosis	0.000102	0.00273	CcSEcCtD
Estramustine—Pruritus—Calcium Acetate—osteoporosis	0.000102	0.00273	CcSEcCtD
Estramustine—Alopecia—Estropipate—osteoporosis	0.000102	0.00272	CcSEcCtD
Estramustine—Thrombophlebitis—Estradiol—osteoporosis	0.000102	0.00272	CcSEcCtD
Estramustine—Depression—Risedronate—osteoporosis	0.000101	0.0027	CcSEcCtD
Estramustine—Alopecia—Alendronate—osteoporosis	0.0001	0.00268	CcSEcCtD
Estramustine—Flatulence—Estropipate—osteoporosis	9.87e-05	0.00264	CcSEcCtD
Estramustine—Diarrhoea—Calcium Acetate—osteoporosis	9.85e-05	0.00264	CcSEcCtD
Estramustine—Alopecia—Ibandronate—osteoporosis	9.75e-05	0.00261	CcSEcCtD
Estramustine—Flatulence—Alendronate—osteoporosis	9.72e-05	0.0026	CcSEcCtD
Estramustine—Muscle spasms—Estropipate—osteoporosis	9.63e-05	0.00258	CcSEcCtD
Estramustine—Flatulence—Raloxifene—osteoporosis	9.56e-05	0.00256	CcSEcCtD
Estramustine—Libido decreased—Estradiol—osteoporosis	9.49e-05	0.00254	CcSEcCtD
Estramustine—Muscle spasms—Alendronate—osteoporosis	9.49e-05	0.00254	CcSEcCtD
Estramustine—Flatulence—Ibandronate—osteoporosis	9.47e-05	0.00253	CcSEcCtD
Estramustine—Abdominal discomfort—Zoledronate—osteoporosis	9.46e-05	0.00253	CcSEcCtD
Estramustine—Mestranol—ESR1—osteoporosis	9.43e-05	0.0564	CrCbGaD
Estramustine—Hot flush—Estradiol—osteoporosis	9.4e-05	0.00252	CcSEcCtD
Estramustine—Pancytopenia—Zoledronate—osteoporosis	9.37e-05	0.00251	CcSEcCtD
Estramustine—Muscle spasms—Raloxifene—osteoporosis	9.33e-05	0.0025	CcSEcCtD
Estramustine—Menopausal symptoms—Estradiol—osteoporosis	9.32e-05	0.0025	CcSEcCtD
Estramustine—Estropipate—SHBG—osteoporosis	9.32e-05	0.0557	CrCbGaD
Estramustine—Muscle spasms—Ibandronate—osteoporosis	9.24e-05	0.00247	CcSEcCtD
Estramustine—Vomiting—Calcium Acetate—osteoporosis	9.15e-05	0.00245	CcSEcCtD
Estramustine—Abdominal discomfort—Conjugated Estrogens—osteoporosis	9.11e-05	0.00244	CcSEcCtD
Estramustine—ESR2—Ovarian Infertility Genes—VDR—osteoporosis	9e-05	0.0271	CbGpPWpGaD
Estramustine—Lethargy—Estradiol—osteoporosis	8.98e-05	0.0024	CcSEcCtD
Estramustine—Cerebrovascular accident—Estradiol—osteoporosis	8.98e-05	0.0024	CcSEcCtD
Estramustine—Depression—Zoledronate—osteoporosis	8.77e-05	0.00235	CcSEcCtD
Estramustine—Disturbance in sexual arousal—Estradiol—osteoporosis	8.73e-05	0.00234	CcSEcCtD
Estramustine—Affect lability—Estradiol—osteoporosis	8.66e-05	0.00232	CcSEcCtD
Estramustine—Nausea—Calcium Acetate—osteoporosis	8.55e-05	0.00229	CcSEcCtD
Estramustine—Anxiety—Estropipate—osteoporosis	8.5e-05	0.00228	CcSEcCtD
Estramustine—Tinnitus—Risedronate—osteoporosis	8.48e-05	0.00227	CcSEcCtD
Estramustine—Depression—Conjugated Estrogens—osteoporosis	8.45e-05	0.00226	CcSEcCtD
Estramustine—Chest pain—Alendronate—osteoporosis	8.4e-05	0.00225	CcSEcCtD
Estramustine—Acute coronary syndrome—Conjugated Estrogens—osteoporosis	8.35e-05	0.00224	CcSEcCtD
Estramustine—Mood swings—Estradiol—osteoporosis	8.33e-05	0.00223	CcSEcCtD
Estramustine—Myocardial infarction—Conjugated Estrogens—osteoporosis	8.3e-05	0.00222	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—ESR2—osteoporosis	8.29e-05	0.0249	CbGpPWpGaD
Estramustine—Chest pain—Raloxifene—osteoporosis	8.26e-05	0.00221	CcSEcCtD
Estramustine—Alopecia—Ethinyl Estradiol—osteoporosis	8.24e-05	0.00221	CcSEcCtD
Estramustine—Estriol—ESR1—osteoporosis	8.23e-05	0.0492	CrCbGaD
Estramustine—Chest pain—Ibandronate—osteoporosis	8.18e-05	0.00219	CcSEcCtD
Estramustine—Oedema—Estropipate—osteoporosis	8.18e-05	0.00219	CcSEcCtD
Estramustine—Anxiety—Ibandronate—osteoporosis	8.15e-05	0.00218	CcSEcCtD
Estramustine—Liver function test abnormal—Estradiol—osteoporosis	8.12e-05	0.00217	CcSEcCtD
Estramustine—Dry skin—Estradiol—osteoporosis	8.06e-05	0.00216	CcSEcCtD
Estramustine—Flushing—Pamidronate—osteoporosis	8.02e-05	0.00215	CcSEcCtD
Estramustine—Chest pain—Calcitriol—osteoporosis	8.01e-05	0.00214	CcSEcCtD
Estramustine—Anxiety—Calcitriol—osteoporosis	7.98e-05	0.00214	CcSEcCtD
Estramustine—ESR2—Nuclear Receptors—VDR—osteoporosis	7.85e-05	0.0236	CbGpPWpGaD
Estramustine—Muscle spasms—Ethinyl Estradiol—osteoporosis	7.81e-05	0.00209	CcSEcCtD
Estramustine—Flatulence—Risedronate—osteoporosis	7.8e-05	0.00209	CcSEcCtD
Estramustine—Thrombocytopenia—Raloxifene—osteoporosis	7.75e-05	0.00208	CcSEcCtD
Estramustine—Alopecia—Pamidronate—osteoporosis	7.64e-05	0.00205	CcSEcCtD
Estramustine—Muscle spasms—Risedronate—osteoporosis	7.61e-05	0.00204	CcSEcCtD
Estramustine—Nausea—Ergocalciferol—osteoporosis	7.55e-05	0.00202	CcSEcCtD
Estramustine—Insomnia—Estropipate—osteoporosis	7.39e-05	0.00198	CcSEcCtD
Estramustine—Flushing—Zoledronate—osteoporosis	7.33e-05	0.00196	CcSEcCtD
Estramustine—MAP2—LKB1 signaling events—MYC—osteoporosis	7.33e-05	0.022	CbGpPWpGaD
Estramustine—Anorexia—Calcitriol—osteoporosis	7.32e-05	0.00196	CcSEcCtD
Estramustine—Ethinyl Estradiol—ESR2—osteoporosis	7.3e-05	0.0436	CrCbGaD
Estramustine—Abdominal discomfort—Estradiol—osteoporosis	7.29e-05	0.00195	CcSEcCtD
Estramustine—Muscle spasms—Pamidronate—osteoporosis	7.24e-05	0.00194	CcSEcCtD
Estramustine—Insomnia—Raloxifene—osteoporosis	7.16e-05	0.00192	CcSEcCtD
Estramustine—Insomnia—Ibandronate—osteoporosis	7.09e-05	0.0019	CcSEcCtD
Estramustine—Alopecia—Zoledronate—osteoporosis	6.98e-05	0.00187	CcSEcCtD
Estramustine—Insomnia—Calcitriol—osteoporosis	6.94e-05	0.00186	CcSEcCtD
Estramustine—Anxiety—Ethinyl Estradiol—osteoporosis	6.89e-05	0.00184	CcSEcCtD
Estramustine—Decreased appetite—Ibandronate—osteoporosis	6.82e-05	0.00182	CcSEcCtD
Estramustine—Depression—Estradiol—osteoporosis	6.76e-05	0.00181	CcSEcCtD
Estramustine—Chest pain—Risedronate—osteoporosis	6.74e-05	0.0018	CcSEcCtD
Estramustine—Leukopenia—Pamidronate—osteoporosis	6.74e-05	0.0018	CcSEcCtD
Estramustine—Alopecia—Conjugated Estrogens—osteoporosis	6.72e-05	0.0018	CcSEcCtD
Estramustine—Anxiety—Risedronate—osteoporosis	6.72e-05	0.0018	CcSEcCtD
Estramustine—Pruritus—Etidronic acid—osteoporosis	6.69e-05	0.00179	CcSEcCtD
Estramustine—Acute coronary syndrome—Estradiol—osteoporosis	6.68e-05	0.00179	CcSEcCtD
Estramustine—Decreased appetite—Calcitriol—osteoporosis	6.67e-05	0.00179	CcSEcCtD
Estramustine—Ethinyl Estradiol—SHBG—osteoporosis	6.66e-05	0.0398	CrCbGaD
Estramustine—Myocardial infarction—Estradiol—osteoporosis	6.64e-05	0.00178	CcSEcCtD
Estramustine—Oedema—Ethinyl Estradiol—osteoporosis	6.63e-05	0.00177	CcSEcCtD
Estramustine—Muscle spasms—Zoledronate—osteoporosis	6.61e-05	0.00177	CcSEcCtD
Estramustine—Flatulence—Conjugated Estrogens—osteoporosis	6.52e-05	0.00175	CcSEcCtD
Estramustine—Diarrhoea—Etidronic acid—osteoporosis	6.47e-05	0.00173	CcSEcCtD
Estramustine—Anxiety—Pamidronate—osteoporosis	6.38e-05	0.00171	CcSEcCtD
Estramustine—Conjugated Estrogens—ESR2—osteoporosis	6.38e-05	0.0381	CrCbGaD
Estramustine—Muscle spasms—Conjugated Estrogens—osteoporosis	6.36e-05	0.0017	CcSEcCtD
Estramustine—Estrone—ESR2—osteoporosis	6.36e-05	0.038	CrCbGaD
Estramustine—Estropipate—ESR1—osteoporosis	6.29e-05	0.0376	CrCbGaD
Estramustine—ESR2—Nuclear Receptor transcription pathway—VDR—osteoporosis	6.2e-05	0.0186	CbGpPWpGaD
Estramustine—Leukopenia—Zoledronate—osteoporosis	6.15e-05	0.00165	CcSEcCtD
Estramustine—Oedema—Pamidronate—osteoporosis	6.14e-05	0.00164	CcSEcCtD
Estramustine—Thrombocytopenia—Pamidronate—osteoporosis	6.01e-05	0.00161	CcSEcCtD
Estramustine—Vomiting—Etidronic acid—osteoporosis	6.01e-05	0.00161	CcSEcCtD
Estramustine—ESR2—Nuclear Receptors—ESR1—osteoporosis	6e-05	0.018	CbGpPWpGaD
Estramustine—Rash—Etidronic acid—osteoporosis	5.96e-05	0.0016	CcSEcCtD
Estramustine—Dermatitis—Etidronic acid—osteoporosis	5.95e-05	0.00159	CcSEcCtD
Estramustine—Headache—Etidronic acid—osteoporosis	5.92e-05	0.00159	CcSEcCtD
Estramustine—Anorexia—Pamidronate—osteoporosis	5.85e-05	0.00157	CcSEcCtD
Estramustine—Chest pain—Zoledronate—osteoporosis	5.85e-05	0.00157	CcSEcCtD
Estramustine—Insomnia—Risedronate—osteoporosis	5.84e-05	0.00156	CcSEcCtD
Estramustine—Anxiety—Zoledronate—osteoporosis	5.83e-05	0.00156	CcSEcCtD
Estramustine—Estrone—SHBG—osteoporosis	5.8e-05	0.0347	CrCbGaD
Estramustine—Pruritus—Estropipate—osteoporosis	5.78e-05	0.00155	CcSEcCtD
Estramustine—Dyspnoea—Risedronate—osteoporosis	5.76e-05	0.00154	CcSEcCtD
Estramustine—Pruritus—Alendronate—osteoporosis	5.7e-05	0.00153	CcSEcCtD
Estramustine—Tinnitus—Estradiol—osteoporosis	5.67e-05	0.00152	CcSEcCtD
Estramustine—Flushing—Estradiol—osteoporosis	5.65e-05	0.00151	CcSEcCtD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—ESR1—osteoporosis	5.64e-05	0.017	CbGpPWpGaD
Estramustine—Chest pain—Conjugated Estrogens—osteoporosis	5.64e-05	0.00151	CcSEcCtD
Estramustine—Anxiety—Conjugated Estrogens—osteoporosis	5.62e-05	0.0015	CcSEcCtD
Estramustine—Nausea—Etidronic acid—osteoporosis	5.61e-05	0.0015	CcSEcCtD
Estramustine—Oedema—Zoledronate—osteoporosis	5.61e-05	0.0015	CcSEcCtD
Estramustine—Diarrhoea—Estropipate—osteoporosis	5.59e-05	0.0015	CcSEcCtD
Estramustine—Insomnia—Pamidronate—osteoporosis	5.56e-05	0.00149	CcSEcCtD
Estramustine—Pruritus—Ibandronate—osteoporosis	5.55e-05	0.00149	CcSEcCtD
Estramustine—Diarrhoea—Alendronate—osteoporosis	5.51e-05	0.00148	CcSEcCtD
Estramustine—Thrombocytopenia—Zoledronate—osteoporosis	5.49e-05	0.00147	CcSEcCtD
Estramustine—Dyspnoea—Pamidronate—osteoporosis	5.48e-05	0.00147	CcSEcCtD
Estramustine—Pruritus—Calcitriol—osteoporosis	5.43e-05	0.00145	CcSEcCtD
Estramustine—Diarrhoea—Raloxifene—osteoporosis	5.42e-05	0.00145	CcSEcCtD
Estramustine—Oedema—Conjugated Estrogens—osteoporosis	5.4e-05	0.00145	CcSEcCtD
Estramustine—Alopecia—Estradiol—osteoporosis	5.38e-05	0.00144	CcSEcCtD
Estramustine—Diarrhoea—Ibandronate—osteoporosis	5.36e-05	0.00144	CcSEcCtD
Estramustine—Anorexia—Zoledronate—osteoporosis	5.35e-05	0.00143	CcSEcCtD
Estramustine—Decreased appetite—Pamidronate—osteoporosis	5.34e-05	0.00143	CcSEcCtD
Estramustine—Diarrhoea—Calcitriol—osteoporosis	5.25e-05	0.00141	CcSEcCtD
Estramustine—Flatulence—Estradiol—osteoporosis	5.22e-05	0.0014	CcSEcCtD
Estramustine—Vomiting—Estropipate—osteoporosis	5.2e-05	0.00139	CcSEcCtD
Estramustine—Rash—Estropipate—osteoporosis	5.15e-05	0.00138	CcSEcCtD
Estramustine—Dermatitis—Estropipate—osteoporosis	5.15e-05	0.00138	CcSEcCtD
Estramustine—Anorexia—Conjugated Estrogens—osteoporosis	5.15e-05	0.00138	CcSEcCtD
Estramustine—Headache—Estropipate—osteoporosis	5.12e-05	0.00137	CcSEcCtD
Estramustine—Vomiting—Alendronate—osteoporosis	5.12e-05	0.00137	CcSEcCtD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—PKM—osteoporosis	5.1e-05	0.0153	CbGpPWpGaD
Estramustine—Muscle spasms—Estradiol—osteoporosis	5.09e-05	0.00136	CcSEcCtD
Estramustine—Rash—Alendronate—osteoporosis	5.08e-05	0.00136	CcSEcCtD
Estramustine—Insomnia—Zoledronate—osteoporosis	5.07e-05	0.00136	CcSEcCtD
Estramustine—Dermatitis—Alendronate—osteoporosis	5.07e-05	0.00136	CcSEcCtD
Estramustine—Headache—Alendronate—osteoporosis	5.04e-05	0.00135	CcSEcCtD
Estramustine—Vomiting—Raloxifene—osteoporosis	5.04e-05	0.00135	CcSEcCtD
Estramustine—Dyspnoea—Zoledronate—osteoporosis	5e-05	0.00134	CcSEcCtD
Estramustine—Rash—Raloxifene—osteoporosis	4.99e-05	0.00134	CcSEcCtD
Estramustine—Dermatitis—Raloxifene—osteoporosis	4.99e-05	0.00134	CcSEcCtD
Estramustine—ESR1—Nuclear Receptors—ESR2—osteoporosis	4.99e-05	0.015	CbGpPWpGaD
Estramustine—Vomiting—Ibandronate—osteoporosis	4.98e-05	0.00133	CcSEcCtD
Estramustine—Headache—Raloxifene—osteoporosis	4.96e-05	0.00133	CcSEcCtD
Estramustine—Rash—Ibandronate—osteoporosis	4.94e-05	0.00132	CcSEcCtD
Estramustine—Dermatitis—Ibandronate—osteoporosis	4.94e-05	0.00132	CcSEcCtD
Estramustine—Headache—Ibandronate—osteoporosis	4.91e-05	0.00132	CcSEcCtD
Estramustine—Insomnia—Conjugated Estrogens—osteoporosis	4.89e-05	0.00131	CcSEcCtD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—IGF1—osteoporosis	4.88e-05	0.0147	CbGpPWpGaD
Estramustine—Vomiting—Calcitriol—osteoporosis	4.88e-05	0.00131	CcSEcCtD
Estramustine—Decreased appetite—Zoledronate—osteoporosis	4.88e-05	0.00131	CcSEcCtD
Estramustine—Nausea—Estropipate—osteoporosis	4.86e-05	0.0013	CcSEcCtD
Estramustine—Rash—Calcitriol—osteoporosis	4.84e-05	0.0013	CcSEcCtD
Estramustine—Dermatitis—Calcitriol—osteoporosis	4.83e-05	0.00129	CcSEcCtD
Estramustine—Estradiol—ESR2—osteoporosis	4.82e-05	0.0288	CrCbGaD
Estramustine—Dyspnoea—Conjugated Estrogens—osteoporosis	4.82e-05	0.00129	CcSEcCtD
Estramustine—Headache—Calcitriol—osteoporosis	4.81e-05	0.00129	CcSEcCtD
Estramustine—Nausea—Alendronate—osteoporosis	4.78e-05	0.00128	CcSEcCtD
Estramustine—ESR2—Nuclear Receptor transcription pathway—ESR1—osteoporosis	4.74e-05	0.0142	CbGpPWpGaD
Estramustine—Nausea—Raloxifene—osteoporosis	4.7e-05	0.00126	CcSEcCtD
Estramustine—Decreased appetite—Conjugated Estrogens—osteoporosis	4.7e-05	0.00126	CcSEcCtD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—ESR2—osteoporosis	4.69e-05	0.0141	CbGpPWpGaD
Estramustine—Pruritus—Ethinyl Estradiol—osteoporosis	4.69e-05	0.00126	CcSEcCtD
Estramustine—Nausea—Ibandronate—osteoporosis	4.66e-05	0.00125	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—GAPDH—osteoporosis	4.61e-05	0.0138	CbGpPWpGaD
Estramustine—Pruritus—Risedronate—osteoporosis	4.57e-05	0.00122	CcSEcCtD
Estramustine—Nausea—Calcitriol—osteoporosis	4.56e-05	0.00122	CcSEcCtD
Estramustine—Diarrhoea—Ethinyl Estradiol—osteoporosis	4.53e-05	0.00121	CcSEcCtD
Estramustine—Chest pain—Estradiol—osteoporosis	4.51e-05	0.00121	CcSEcCtD
Estramustine—Ethinyl Estradiol—ESR1—osteoporosis	4.5e-05	0.0269	CrCbGaD
Estramustine—Anxiety—Estradiol—osteoporosis	4.49e-05	0.0012	CcSEcCtD
Estramustine—Diarrhoea—Risedronate—osteoporosis	4.42e-05	0.00118	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—COL1A2—osteoporosis	4.41e-05	0.0133	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—IL6R—osteoporosis	4.41e-05	0.0133	CbGpPWpGaD
Estramustine—Estradiol—SHBG—osteoporosis	4.39e-05	0.0263	CrCbGaD
Estramustine—Pruritus—Pamidronate—osteoporosis	4.35e-05	0.00116	CcSEcCtD
Estramustine—Oedema—Estradiol—osteoporosis	4.32e-05	0.00116	CcSEcCtD
Estramustine—Vomiting—Ethinyl Estradiol—osteoporosis	4.21e-05	0.00113	CcSEcCtD
Estramustine—Diarrhoea—Pamidronate—osteoporosis	4.2e-05	0.00113	CcSEcCtD
Estramustine—ESR1—AP-1 transcription factor network—NFATC1—osteoporosis	4.19e-05	0.0126	CbGpPWpGaD
Estramustine—Rash—Ethinyl Estradiol—osteoporosis	4.18e-05	0.00112	CcSEcCtD
Estramustine—Dermatitis—Ethinyl Estradiol—osteoporosis	4.17e-05	0.00112	CcSEcCtD
Estramustine—Headache—Ethinyl Estradiol—osteoporosis	4.15e-05	0.00111	CcSEcCtD
Estramustine—Vomiting—Risedronate—osteoporosis	4.11e-05	0.0011	CcSEcCtD
Estramustine—Rash—Risedronate—osteoporosis	4.07e-05	0.00109	CcSEcCtD
Estramustine—Dermatitis—Risedronate—osteoporosis	4.07e-05	0.00109	CcSEcCtD
Estramustine—Headache—Risedronate—osteoporosis	4.05e-05	0.00108	CcSEcCtD
Estramustine—ABCB1—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	3.98e-05	0.012	CbGpPWpGaD
Estramustine—Pruritus—Zoledronate—osteoporosis	3.97e-05	0.00106	CcSEcCtD
Estramustine—ESR1—Nuclear Receptors—VDR—osteoporosis	3.96e-05	0.0119	CbGpPWpGaD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—ESR1—osteoporosis	3.95e-05	0.0119	CbGpPWpGaD
Estramustine—ESR1—Nuclear Receptor transcription pathway—ESR2—osteoporosis	3.94e-05	0.0118	CbGpPWpGaD
Estramustine—Nausea—Ethinyl Estradiol—osteoporosis	3.94e-05	0.00105	CcSEcCtD
Estramustine—Conjugated Estrogens—ESR1—osteoporosis	3.93e-05	0.0235	CrCbGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	3.93e-05	0.0118	CbGpPWpGaD
Estramustine—Estrone—ESR1—osteoporosis	3.92e-05	0.0234	CrCbGaD
Estramustine—Insomnia—Estradiol—osteoporosis	3.91e-05	0.00105	CcSEcCtD
Estramustine—Vomiting—Pamidronate—osteoporosis	3.91e-05	0.00105	CcSEcCtD
Estramustine—Rash—Pamidronate—osteoporosis	3.87e-05	0.00104	CcSEcCtD
Estramustine—Dermatitis—Pamidronate—osteoporosis	3.87e-05	0.00104	CcSEcCtD
Estramustine—Dyspnoea—Estradiol—osteoporosis	3.85e-05	0.00103	CcSEcCtD
Estramustine—Headache—Pamidronate—osteoporosis	3.85e-05	0.00103	CcSEcCtD
Estramustine—Diarrhoea—Zoledronate—osteoporosis	3.84e-05	0.00103	CcSEcCtD
Estramustine—Nausea—Risedronate—osteoporosis	3.84e-05	0.00103	CcSEcCtD
Estramustine—Pruritus—Conjugated Estrogens—osteoporosis	3.82e-05	0.00102	CcSEcCtD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	3.82e-05	0.0115	CbGpPWpGaD
Estramustine—Decreased appetite—Estradiol—osteoporosis	3.76e-05	0.00101	CcSEcCtD
Estramustine—Diarrhoea—Conjugated Estrogens—osteoporosis	3.7e-05	0.00099	CcSEcCtD
Estramustine—Nausea—Pamidronate—osteoporosis	3.65e-05	0.000977	CcSEcCtD
Estramustine—Vomiting—Zoledronate—osteoporosis	3.57e-05	0.000955	CcSEcCtD
Estramustine—ABCB1—Allograft Rejection—TUBA1B—osteoporosis	3.56e-05	0.0107	CbGpPWpGaD
Estramustine—Rash—Zoledronate—osteoporosis	3.54e-05	0.000947	CcSEcCtD
Estramustine—Dermatitis—Zoledronate—osteoporosis	3.53e-05	0.000946	CcSEcCtD
Estramustine—Testosterone—SHBG—osteoporosis	3.53e-05	0.0211	CrCbGaD
Estramustine—Headache—Zoledronate—osteoporosis	3.51e-05	0.000941	CcSEcCtD
Estramustine—Vomiting—Conjugated Estrogens—osteoporosis	3.43e-05	0.00092	CcSEcCtD
Estramustine—Rash—Conjugated Estrogens—osteoporosis	3.41e-05	0.000912	CcSEcCtD
Estramustine—Dermatitis—Conjugated Estrogens—osteoporosis	3.4e-05	0.000911	CcSEcCtD
Estramustine—Headache—Conjugated Estrogens—osteoporosis	3.38e-05	0.000906	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—IL1B—osteoporosis	3.36e-05	0.0101	CbGpPWpGaD
Estramustine—Nausea—Zoledronate—osteoporosis	3.33e-05	0.000892	CcSEcCtD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—ESR2—osteoporosis	3.29e-05	0.00987	CbGpPWpGaD
Estramustine—Nausea—Conjugated Estrogens—osteoporosis	3.21e-05	0.000859	CcSEcCtD
Estramustine—ESR1—Nuclear Receptor transcription pathway—VDR—osteoporosis	3.13e-05	0.0094	CbGpPWpGaD
Estramustine—Pruritus—Estradiol—osteoporosis	3.06e-05	0.000819	CcSEcCtD
Estramustine—Estradiol—ESR1—osteoporosis	2.97e-05	0.0177	CrCbGaD
Estramustine—Diarrhoea—Estradiol—osteoporosis	2.96e-05	0.000792	CcSEcCtD
Estramustine—Vomiting—Estradiol—osteoporosis	2.75e-05	0.000736	CcSEcCtD
Estramustine—Rash—Estradiol—osteoporosis	2.73e-05	0.00073	CcSEcCtD
Estramustine—Dermatitis—Estradiol—osteoporosis	2.72e-05	0.000729	CcSEcCtD
Estramustine—Headache—Estradiol—osteoporosis	2.71e-05	0.000725	CcSEcCtD
Estramustine—Testosterone—CYP19A1—osteoporosis	2.59e-05	0.0155	CrCbGaD
Estramustine—Nausea—Estradiol—osteoporosis	2.57e-05	0.000688	CcSEcCtD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—IGF1—osteoporosis	2.46e-05	0.0074	CbGpPWpGaD
Estramustine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	2.45e-05	0.00738	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—TNF—osteoporosis	2.43e-05	0.00731	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—RAP1A—osteoporosis	2.32e-05	0.00698	CbGpPWpGaD
Estramustine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	2.29e-05	0.00688	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	2.16e-05	0.00649	CbGpPWpGaD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—MYC—osteoporosis	2.06e-05	0.00618	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—IL6—osteoporosis	1.96e-05	0.0059	CbGpPWpGaD
Estramustine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	1.95e-05	0.00586	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	1.93e-05	0.00579	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	1.93e-05	0.00578	CbGpPWpGaD
Estramustine—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	1.92e-05	0.00578	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—LEP—osteoporosis	1.84e-05	0.00552	CbGpPWpGaD
Estramustine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	1.84e-05	0.00552	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—IL6R—osteoporosis	1.7e-05	0.00511	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—U2AF1—osteoporosis	1.7e-05	0.00509	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.65e-05	0.00495	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—IRS1—osteoporosis	1.64e-05	0.00493	CbGpPWpGaD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	1.58e-05	0.00475	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—KL—osteoporosis	1.56e-05	0.00468	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CYP19A1—osteoporosis	1.5e-05	0.00451	CbGpPWpGaD
Estramustine—ESR1—FOXM1 transcription factor network—MYC—osteoporosis	1.45e-05	0.00436	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.43e-05	0.00428	CbGpPWpGaD
Estramustine—ESR1—LKB1 signaling events—MYC—osteoporosis	1.42e-05	0.00428	CbGpPWpGaD
Estramustine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	1.41e-05	0.00424	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	1.37e-05	0.00412	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—MYC—osteoporosis	1.35e-05	0.00406	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—IL1B—osteoporosis	1.29e-05	0.00389	CbGpPWpGaD
Estramustine—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	1.27e-05	0.00381	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—RPL24—osteoporosis	1.26e-05	0.00379	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—TNF—osteoporosis	1.26e-05	0.00378	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—IL1B—osteoporosis	1.17e-05	0.00352	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	1.08e-05	0.00324	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—VDR—osteoporosis	1.07e-05	0.00322	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—IRS2—osteoporosis	1.07e-05	0.00321	CbGpPWpGaD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—MYC—osteoporosis	1.04e-05	0.00311	CbGpPWpGaD
Estramustine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	1.02e-05	0.00308	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	1.02e-05	0.00306	CbGpPWpGaD
Estramustine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	1.01e-05	0.00304	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—MYC—osteoporosis	9.87e-06	0.00297	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—TGFB1—osteoporosis	9.85e-06	0.00296	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—MYC—osteoporosis	9.65e-06	0.0029	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—TGFB1—osteoporosis	9.62e-06	0.00289	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—TNF—osteoporosis	9.39e-06	0.00282	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—IRS1—osteoporosis	9.37e-06	0.00281	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—IRS1—osteoporosis	9.32e-06	0.0028	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—IL6R—osteoporosis	8.76e-06	0.00263	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	8.58e-06	0.00258	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	8.57e-06	0.00257	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—U2AF1—osteoporosis	8.55e-06	0.00257	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	8.55e-06	0.00257	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	8.39e-06	0.00252	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—IL6—osteoporosis	8.32e-06	0.0025	CbGpPWpGaD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	8.3e-06	0.00249	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	8.28e-06	0.00249	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—ESR1—osteoporosis	8.19e-06	0.00246	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	7.98e-06	0.0024	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—IL6—osteoporosis	7.58e-06	0.00228	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—PSMA2—osteoporosis	7.27e-06	0.00218	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—PSMA5—osteoporosis	7.27e-06	0.00218	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—IL6—osteoporosis	7.25e-06	0.00218	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	7.25e-06	0.00218	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	7.19e-06	0.00216	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—ESR2—osteoporosis	6.81e-06	0.00204	CbGpPWpGaD
Estramustine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	6.79e-06	0.00204	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SOST—osteoporosis	6.41e-06	0.00193	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—RPL24—osteoporosis	6.35e-06	0.00191	CbGpPWpGaD
Estramustine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	6.15e-06	0.00185	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IL1B—osteoporosis	5.95e-06	0.00179	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CALCR—osteoporosis	5.8e-06	0.00174	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PTH1R—osteoporosis	5.8e-06	0.00174	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	5.69e-06	0.00171	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—VDR—osteoporosis	5.4e-06	0.00162	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—MYC—osteoporosis	5.22e-06	0.00157	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—VDR—osteoporosis	5.16e-06	0.00155	CbGpPWpGaD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.99e-06	0.0015	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—TGFB1—osteoporosis	4.62e-06	0.00139	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MGLL—osteoporosis	4.61e-06	0.00138	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—LRP5—osteoporosis	4.5e-06	0.00135	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	4.41e-06	0.00132	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	4.4e-06	0.00132	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	4.35e-06	0.00131	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	4.32e-06	0.0013	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—TNF—osteoporosis	4.32e-06	0.0013	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	4.31e-06	0.0013	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—LRP6—osteoporosis	4.3e-06	0.00129	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—MYC—osteoporosis	4.26e-06	0.00128	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PKM—osteoporosis	4.06e-06	0.00122	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—FDPS—osteoporosis	4.06e-06	0.00122	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	4.03e-06	0.00121	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—ESR1—osteoporosis	3.94e-06	0.00118	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—IL6—osteoporosis	3.9e-06	0.00117	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PGLS—osteoporosis	3.85e-06	0.00116	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GPD2—osteoporosis	3.85e-06	0.00116	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	3.8e-06	0.00114	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—PSMA2—osteoporosis	3.67e-06	0.0011	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—PSMA5—osteoporosis	3.67e-06	0.0011	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TLN1—osteoporosis	3.63e-06	0.00109	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ATIC—osteoporosis	3.52e-06	0.00106	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PNP—osteoporosis	3.52e-06	0.00106	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—ESR2—osteoporosis	3.28e-06	0.000984	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—P4HB—osteoporosis	3.13e-06	0.000941	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PTH—osteoporosis	3.05e-06	0.000915	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—RAP1A—osteoporosis	2.99e-06	0.000899	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—OXCT1—osteoporosis	2.99e-06	0.000899	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CA2—osteoporosis	2.99e-06	0.000899	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CNR2—osteoporosis	2.97e-06	0.000892	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NFATC1—osteoporosis	2.92e-06	0.000877	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—MGLL—osteoporosis	2.91e-06	0.000876	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—DKK1—osteoporosis	2.9e-06	0.00087	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—WNT1—osteoporosis	2.79e-06	0.000838	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FGA—osteoporosis	2.71e-06	0.000816	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—POMC—osteoporosis	2.65e-06	0.000796	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—VDR—osteoporosis	2.6e-06	0.000781	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PTHLH—osteoporosis	2.52e-06	0.000758	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—BMP2—osteoporosis	2.52e-06	0.000758	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—FDPS—osteoporosis	2.5e-06	0.000751	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PKM—osteoporosis	2.5e-06	0.000751	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—IDH2—osteoporosis	2.48e-06	0.000745	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FGB—osteoporosis	2.47e-06	0.000742	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PSMA2—osteoporosis	2.38e-06	0.000716	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PSMA5—osteoporosis	2.38e-06	0.000716	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GPD2—osteoporosis	2.37e-06	0.000712	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PGLS—osteoporosis	2.37e-06	0.000712	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP27A1—osteoporosis	2.33e-06	0.0007	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.29e-06	0.000687	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.28e-06	0.000685	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ACP5—osteoporosis	2.27e-06	0.000681	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CALCA—osteoporosis	2.22e-06	0.000668	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ATIC—osteoporosis	2.17e-06	0.000651	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PNP—osteoporosis	2.17e-06	0.000651	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—MYC—osteoporosis	2.15e-06	0.000645	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.14e-06	0.000642	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.13e-06	0.00064	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—TPI1—osteoporosis	2.11e-06	0.000633	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—MYC—osteoporosis	2.05e-06	0.000616	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—KL—osteoporosis	2.02e-06	0.000606	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—P4HB—osteoporosis	1.98e-06	0.000595	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GAPDH—osteoporosis	1.94e-06	0.000584	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—RAP1A—osteoporosis	1.89e-06	0.000569	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—OXCT1—osteoporosis	1.84e-06	0.000554	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CA2—osteoporosis	1.84e-06	0.000554	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—MGLL—osteoporosis	1.8e-06	0.00054	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ADCY5—osteoporosis	1.58e-06	0.000475	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ENO1—osteoporosis	1.53e-06	0.00046	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SPP1—osteoporosis	1.53e-06	0.000459	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—IDH2—osteoporosis	1.53e-06	0.000459	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PSMA5—osteoporosis	1.51e-06	0.000453	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PSMA2—osteoporosis	1.51e-06	0.000453	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.44e-06	0.000431	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ACP5—osteoporosis	1.4e-06	0.00042	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IRS2—osteoporosis	1.38e-06	0.000415	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—LEP—osteoporosis	1.35e-06	0.000407	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—TPI1—osteoporosis	1.3e-06	0.00039	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP19A1—osteoporosis	1.22e-06	0.000368	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—P4HB—osteoporosis	1.22e-06	0.000367	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IRS1—osteoporosis	1.21e-06	0.000363	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GAPDH—osteoporosis	1.2e-06	0.00036	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—RAP1A—osteoporosis	1.17e-06	0.000351	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—POMC—osteoporosis	1.16e-06	0.000349	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IL6R—osteoporosis	1.13e-06	0.000341	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IGF1—osteoporosis	1.12e-06	0.000336	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—MYC—osteoporosis	1.03e-06	0.000311	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ADCY5—osteoporosis	1e-06	0.0003	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GPX1—osteoporosis	9.97e-07	0.000299	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ENO1—osteoporosis	9.43e-07	0.000283	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PSMA5—osteoporosis	9.3e-07	0.000279	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PSMA2—osteoporosis	9.3e-07	0.000279	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—MTHFR—osteoporosis	9.2e-07	0.000276	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP19A1—osteoporosis	7.54e-07	0.000227	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—POMC—osteoporosis	7.36e-07	0.000221	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MYC—osteoporosis	6.72e-07	0.000202	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TGFB1—osteoporosis	6.7e-07	0.000201	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ADCY5—osteoporosis	6.16e-07	0.000185	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GPX1—osteoporosis	6.14e-07	0.000184	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—MTHFR—osteoporosis	5.67e-07	0.00017	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IL6—osteoporosis	5.05e-07	0.000152	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—POMC—osteoporosis	4.53e-07	0.000136	CbGpPWpGaD
